Effects of Aminoguanidine on Kidney Health in Diabetic Rats
Author Information
Author(s): DILEK GOGAS YAVUZ, HALIL ONDER ERSOZ, MORVET TUNCEL, MUSTAFA F SARGON, BELGIN KO(OKKAYA, RENGIN AHISKALI, SEMA AKALIN
Primary Institution: Marmara University, Istanbul, Turkey; Hacettepe University, Ankara, Turkey
Hypothesis
The beneficial effects of aminoguanidine on diabetic kidney could be by preventing the loss of glomerular anionic charge.
Conclusion
Aminoguanidine treatment reduces urinary albumin excretion, prevents glomerular basement membrane thickening, and protects from the loss of GBM anionic content in diabetic rats.
Supporting Evidence
- Aminoguanidine treatment reduced urinary albumin excretion in diabetic rats.
- Diabetic rats showed increased GBM thickness compared to healthy controls.
- AG treated diabetic rats had similar alcian blue staining patterns to healthy controls.
Takeaway
Aminoguanidine helps keep the kidneys of diabetic rats healthy by stopping them from leaking protein and getting thicker.
Methodology
Diabetic rats were treated with aminoguanidine and compared to control groups over an 8-week period, measuring urinary albumin, heparan sulfate, and GBM thickness.
Limitations
The study was conducted on a specific rat model, which may not fully represent human diabetic conditions.
Participant Demographics
Female Wistar rats, aged 10 weeks.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website